Joseph Broderick
Director · University of Cincinnati Medical Center Inc.
Credentials: · · · · · ·
History
Presentneurology Department · University of Cincinnati Medical Center Inc.
1987–1988- 1983–1987
- 1974–1978
Xavier University
Research
Thrombectomy for Stroke at 6 to 16 Hours with Selection by Perfusion Imaging
New England Journal of Medicine · 2018 · 3,826 citations
Stroke · 2013 · 2,572 citations
The Lancet · 2004 · 1,957 citations
125 papers · 9 as a fellow
125 papers · 17 as a resident
- DK
114 papers · 1 as a fellow
96 papers · 3 as a fellow
85 papers · 21 as a fellow
- TT
78 papers
70 papers
67 papers · 6 as a fellow
Grants
- 2006–2031
Cerebrovascular Fellowship Training Program
National Institute of Neurological Disorders and Stroke · T32
Contact PI · $1.7M · University of Cincinnati
- 2013–2028
NIH StrokeNet National Clinical Coordinating Center (NCC)
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $32.3M · University of Cincinnati
- 2020–2026
FVIIa for Acute Hemorrhagic Stroke Administered at Earliest Time (FASTEST) Trial
National Institute of Neurological Disorders and Stroke · U01
Contact PI · $24.3M · University of Cincinnati
- 2017–2025
AtRial Cardiopathy and Antithrombotic Drugs In Prevention After Cryptogenicstroke (ARCADIA)
National Institute of Neurological Disorders and Stroke · U01
PI · $22M · Columbia University Health Sciences
Clinical trials
- 2025–2029
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Principal investigator · Recruiting · Phase 3
Joseph Broderick, MD
- 2021–2028
Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial
Principal investigator · Active not recruiting · Phase 3
Joseph Broderick, MD
- 2006–2013
Interventional Management of Stroke (IMS) III Trial
Principal investigator · Terminated · Phase 3
Joseph Broderick
- 2003–2007
Interventional Management of Stroke (IMS) II Study
Principal investigator · Completed · Phase 2
University of Cincinnati